nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—Dysphagia—Sorafenib—liver cancer	0.00878	0.00878	CcSEcCtD
Frovatriptan—Urine abnormality—Doxorubicin—liver cancer	0.00865	0.00865	CcSEcCtD
Frovatriptan—Urine analysis abnormal—Doxorubicin—liver cancer	0.00814	0.00814	CcSEcCtD
Frovatriptan—Acute coronary syndrome—Sorafenib—liver cancer	0.00772	0.00772	CcSEcCtD
Frovatriptan—Myocardial infarction—Sorafenib—liver cancer	0.00768	0.00768	CcSEcCtD
Frovatriptan—Stomatitis—Sorafenib—liver cancer	0.00763	0.00763	CcSEcCtD
Frovatriptan—Hyperventilation—Epirubicin—liver cancer	0.00752	0.00752	CcSEcCtD
Frovatriptan—Epistaxis—Sorafenib—liver cancer	0.00739	0.00739	CcSEcCtD
Frovatriptan—Laryngitis—Epirubicin—liver cancer	0.00718	0.00718	CcSEcCtD
Frovatriptan—Haemoglobin—Sorafenib—liver cancer	0.00707	0.00707	CcSEcCtD
Frovatriptan—Haemorrhage—Sorafenib—liver cancer	0.00703	0.00703	CcSEcCtD
Frovatriptan—Hyperventilation—Doxorubicin—liver cancer	0.00696	0.00696	CcSEcCtD
Frovatriptan—Urinary tract disorder—Sorafenib—liver cancer	0.00694	0.00694	CcSEcCtD
Frovatriptan—Urethral disorder—Sorafenib—liver cancer	0.00689	0.00689	CcSEcCtD
Frovatriptan—Laryngitis—Doxorubicin—liver cancer	0.00664	0.00664	CcSEcCtD
Frovatriptan—Hyperaesthesia—Epirubicin—liver cancer	0.00659	0.00659	CcSEcCtD
Frovatriptan—Tinnitus—Sorafenib—liver cancer	0.00656	0.00656	CcSEcCtD
Frovatriptan—Flushing—Sorafenib—liver cancer	0.00653	0.00653	CcSEcCtD
Frovatriptan—Rigors—Epirubicin—liver cancer	0.00634	0.00634	CcSEcCtD
Frovatriptan—Arrhythmia—Sorafenib—liver cancer	0.00628	0.00628	CcSEcCtD
Frovatriptan—Mental disorder—Sorafenib—liver cancer	0.00616	0.00616	CcSEcCtD
Frovatriptan—Malnutrition—Sorafenib—liver cancer	0.00612	0.00612	CcSEcCtD
Frovatriptan—Hyperaesthesia—Doxorubicin—liver cancer	0.0061	0.0061	CcSEcCtD
Frovatriptan—Dysgeusia—Sorafenib—liver cancer	0.00599	0.00599	CcSEcCtD
Frovatriptan—Cardiovascular disorder—Epirubicin—liver cancer	0.00589	0.00589	CcSEcCtD
Frovatriptan—Muscle spasms—Sorafenib—liver cancer	0.00588	0.00588	CcSEcCtD
Frovatriptan—Rigors—Doxorubicin—liver cancer	0.00586	0.00586	CcSEcCtD
Frovatriptan—Arthropathy—Epirubicin—liver cancer	0.00569	0.00569	CcSEcCtD
Frovatriptan—Thinking abnormal—Epirubicin—liver cancer	0.00565	0.00565	CcSEcCtD
Frovatriptan—Hypocalcaemia—Epirubicin—liver cancer	0.00565	0.00565	CcSEcCtD
Frovatriptan—Nocturia—Epirubicin—liver cancer	0.00558	0.00558	CcSEcCtD
Frovatriptan—Syncope—Sorafenib—liver cancer	0.00549	0.00549	CcSEcCtD
Frovatriptan—Cardiovascular disorder—Doxorubicin—liver cancer	0.00545	0.00545	CcSEcCtD
Frovatriptan—Bone pain—Epirubicin—liver cancer	0.0054	0.0054	CcSEcCtD
Frovatriptan—Loss of consciousness—Sorafenib—liver cancer	0.00538	0.00538	CcSEcCtD
Frovatriptan—Gait disturbance—Epirubicin—liver cancer	0.0053	0.0053	CcSEcCtD
Frovatriptan—Arthropathy—Doxorubicin—liver cancer	0.00526	0.00526	CcSEcCtD
Frovatriptan—Thinking abnormal—Doxorubicin—liver cancer	0.00523	0.00523	CcSEcCtD
Frovatriptan—Hypocalcaemia—Doxorubicin—liver cancer	0.00523	0.00523	CcSEcCtD
Frovatriptan—Arthralgia—Sorafenib—liver cancer	0.00521	0.00521	CcSEcCtD
Frovatriptan—Myalgia—Sorafenib—liver cancer	0.00521	0.00521	CcSEcCtD
Frovatriptan—Ventricular tachycardia—Epirubicin—liver cancer	0.00517	0.00517	CcSEcCtD
Frovatriptan—Hiccups—Epirubicin—liver cancer	0.00517	0.00517	CcSEcCtD
Frovatriptan—Nocturia—Doxorubicin—liver cancer	0.00516	0.00516	CcSEcCtD
Frovatriptan—Dry mouth—Sorafenib—liver cancer	0.0051	0.0051	CcSEcCtD
Frovatriptan—Eructation—Epirubicin—liver cancer	0.00508	0.00508	CcSEcCtD
Frovatriptan—Salivary hypersecretion—Epirubicin—liver cancer	0.00503	0.00503	CcSEcCtD
Frovatriptan—Bone pain—Doxorubicin—liver cancer	0.005	0.005	CcSEcCtD
Frovatriptan—Anaphylactic shock—Sorafenib—liver cancer	0.005	0.005	CcSEcCtD
Frovatriptan—Shock—Sorafenib—liver cancer	0.00491	0.00491	CcSEcCtD
Frovatriptan—Gait disturbance—Doxorubicin—liver cancer	0.00491	0.00491	CcSEcCtD
Frovatriptan—Ventricular tachycardia—Doxorubicin—liver cancer	0.00479	0.00479	CcSEcCtD
Frovatriptan—Hiccups—Doxorubicin—liver cancer	0.00479	0.00479	CcSEcCtD
Frovatriptan—Anorexia—Sorafenib—liver cancer	0.00476	0.00476	CcSEcCtD
Frovatriptan—Cramps of lower extremities—Epirubicin—liver cancer	0.00475	0.00475	CcSEcCtD
Frovatriptan—Eructation—Doxorubicin—liver cancer	0.0047	0.0047	CcSEcCtD
Frovatriptan—Salivary hypersecretion—Doxorubicin—liver cancer	0.00465	0.00465	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00455	0.00455	CcSEcCtD
Frovatriptan—Hypertonia—Epirubicin—liver cancer	0.00454	0.00454	CcSEcCtD
Frovatriptan—Abnormal vision—Epirubicin—liver cancer	0.00451	0.00451	CcSEcCtD
Frovatriptan—Mental disability—Epirubicin—liver cancer	0.00449	0.00449	CcSEcCtD
Frovatriptan—Dyspnoea—Sorafenib—liver cancer	0.00445	0.00445	CcSEcCtD
Frovatriptan—Cramps of lower extremities—Doxorubicin—liver cancer	0.0044	0.0044	CcSEcCtD
Frovatriptan—Dyspepsia—Sorafenib—liver cancer	0.0044	0.0044	CcSEcCtD
Frovatriptan—Decreased appetite—Sorafenib—liver cancer	0.00434	0.00434	CcSEcCtD
Frovatriptan—Fatigue—Sorafenib—liver cancer	0.00431	0.00431	CcSEcCtD
Frovatriptan—Pain—Sorafenib—liver cancer	0.00427	0.00427	CcSEcCtD
Frovatriptan—Constipation—Sorafenib—liver cancer	0.00427	0.00427	CcSEcCtD
Frovatriptan—Vascular purpura—Epirubicin—liver cancer	0.0042	0.0042	CcSEcCtD
Frovatriptan—Hypertonia—Doxorubicin—liver cancer	0.0042	0.0042	CcSEcCtD
Frovatriptan—Abnormal vision—Doxorubicin—liver cancer	0.00418	0.00418	CcSEcCtD
Frovatriptan—Eye pain—Epirubicin—liver cancer	0.00416	0.00416	CcSEcCtD
Frovatriptan—Mental disability—Doxorubicin—liver cancer	0.00415	0.00415	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Sorafenib—liver cancer	0.00408	0.00408	CcSEcCtD
Frovatriptan—Hot flush—Epirubicin—liver cancer	0.00402	0.00402	CcSEcCtD
Frovatriptan—Menopausal symptoms—Epirubicin—liver cancer	0.00398	0.00398	CcSEcCtD
Frovatriptan—Body temperature increased—Sorafenib—liver cancer	0.00395	0.00395	CcSEcCtD
Frovatriptan—Abdominal pain—Sorafenib—liver cancer	0.00395	0.00395	CcSEcCtD
Frovatriptan—Dermatitis bullous—Epirubicin—liver cancer	0.00393	0.00393	CcSEcCtD
Frovatriptan—Purpura—Epirubicin—liver cancer	0.0039	0.0039	CcSEcCtD
Frovatriptan—Vascular purpura—Doxorubicin—liver cancer	0.00388	0.00388	CcSEcCtD
Frovatriptan—Eye pain—Doxorubicin—liver cancer	0.00385	0.00385	CcSEcCtD
Frovatriptan—Hypoglycaemia—Epirubicin—liver cancer	0.00385	0.00385	CcSEcCtD
Frovatriptan—Osteoarthritis—Epirubicin—liver cancer	0.00376	0.00376	CcSEcCtD
Frovatriptan—Pain in extremity—Epirubicin—liver cancer	0.00376	0.00376	CcSEcCtD
Frovatriptan—Hot flush—Doxorubicin—liver cancer	0.00372	0.00372	CcSEcCtD
Frovatriptan—Affect lability—Epirubicin—liver cancer	0.0037	0.0037	CcSEcCtD
Frovatriptan—Migraine—Epirubicin—liver cancer	0.0037	0.0037	CcSEcCtD
Frovatriptan—Menopausal symptoms—Doxorubicin—liver cancer	0.00368	0.00368	CcSEcCtD
Frovatriptan—Hypersensitivity—Sorafenib—liver cancer	0.00368	0.00368	CcSEcCtD
Frovatriptan—Dermatitis bullous—Doxorubicin—liver cancer	0.00364	0.00364	CcSEcCtD
Frovatriptan—Purpura—Doxorubicin—liver cancer	0.00361	0.00361	CcSEcCtD
Frovatriptan—Asthenia—Sorafenib—liver cancer	0.00358	0.00358	CcSEcCtD
Frovatriptan—Hypoglycaemia—Doxorubicin—liver cancer	0.00356	0.00356	CcSEcCtD
Frovatriptan—Mood swings—Epirubicin—liver cancer	0.00356	0.00356	CcSEcCtD
Frovatriptan—Pruritus—Sorafenib—liver cancer	0.00353	0.00353	CcSEcCtD
Frovatriptan—Ataxia—Epirubicin—liver cancer	0.00353	0.00353	CcSEcCtD
Frovatriptan—Dehydration—Epirubicin—liver cancer	0.00349	0.00349	CcSEcCtD
Frovatriptan—Osteoarthritis—Doxorubicin—liver cancer	0.00348	0.00348	CcSEcCtD
Frovatriptan—Pain in extremity—Doxorubicin—liver cancer	0.00348	0.00348	CcSEcCtD
Frovatriptan—Affect lability—Doxorubicin—liver cancer	0.00342	0.00342	CcSEcCtD
Frovatriptan—Migraine—Doxorubicin—liver cancer	0.00342	0.00342	CcSEcCtD
Frovatriptan—Diarrhoea—Sorafenib—liver cancer	0.00342	0.00342	CcSEcCtD
Frovatriptan—Muscular weakness—Epirubicin—liver cancer	0.00331	0.00331	CcSEcCtD
Frovatriptan—Dizziness—Sorafenib—liver cancer	0.0033	0.0033	CcSEcCtD
Frovatriptan—Mood swings—Doxorubicin—liver cancer	0.00329	0.00329	CcSEcCtD
Frovatriptan—Ataxia—Doxorubicin—liver cancer	0.00327	0.00327	CcSEcCtD
Frovatriptan—Dysphagia—Epirubicin—liver cancer	0.00325	0.00325	CcSEcCtD
Frovatriptan—Dehydration—Doxorubicin—liver cancer	0.00323	0.00323	CcSEcCtD
Frovatriptan—Vomiting—Sorafenib—liver cancer	0.00318	0.00318	CcSEcCtD
Frovatriptan—Headache—Sorafenib—liver cancer	0.00313	0.00313	CcSEcCtD
Frovatriptan—Muscular weakness—Doxorubicin—liver cancer	0.00307	0.00307	CcSEcCtD
Frovatriptan—Dysphagia—Doxorubicin—liver cancer	0.003	0.003	CcSEcCtD
Frovatriptan—Pollakiuria—Epirubicin—liver cancer	0.003	0.003	CcSEcCtD
Frovatriptan—Nausea—Sorafenib—liver cancer	0.00297	0.00297	CcSEcCtD
Frovatriptan—Stomatitis—Epirubicin—liver cancer	0.00282	0.00282	CcSEcCtD
Frovatriptan—Conjunctivitis—Epirubicin—liver cancer	0.00281	0.00281	CcSEcCtD
Frovatriptan—Pollakiuria—Doxorubicin—liver cancer	0.00277	0.00277	CcSEcCtD
Frovatriptan—Epistaxis—Epirubicin—liver cancer	0.00273	0.00273	CcSEcCtD
Frovatriptan—Sinusitis—Epirubicin—liver cancer	0.00272	0.00272	CcSEcCtD
Frovatriptan—Bradycardia—Epirubicin—liver cancer	0.00265	0.00265	CcSEcCtD
Frovatriptan—Haemoglobin—Epirubicin—liver cancer	0.00261	0.00261	CcSEcCtD
Frovatriptan—Stomatitis—Doxorubicin—liver cancer	0.00261	0.00261	CcSEcCtD
Frovatriptan—Rhinitis—Epirubicin—liver cancer	0.0026	0.0026	CcSEcCtD
Frovatriptan—Conjunctivitis—Doxorubicin—liver cancer	0.0026	0.0026	CcSEcCtD
Frovatriptan—Haemorrhage—Epirubicin—liver cancer	0.0026	0.0026	CcSEcCtD
Frovatriptan—Hypoaesthesia—Epirubicin—liver cancer	0.00259	0.00259	CcSEcCtD
Frovatriptan—Pharyngitis—Epirubicin—liver cancer	0.00258	0.00258	CcSEcCtD
Frovatriptan—Urinary tract disorder—Epirubicin—liver cancer	0.00257	0.00257	CcSEcCtD
Frovatriptan—Urethral disorder—Epirubicin—liver cancer	0.00255	0.00255	CcSEcCtD
Frovatriptan—Epistaxis—Doxorubicin—liver cancer	0.00253	0.00253	CcSEcCtD
Frovatriptan—Sinusitis—Doxorubicin—liver cancer	0.00251	0.00251	CcSEcCtD
Frovatriptan—Visual impairment—Epirubicin—liver cancer	0.0025	0.0025	CcSEcCtD
Frovatriptan—Bradycardia—Doxorubicin—liver cancer	0.00245	0.00245	CcSEcCtD
Frovatriptan—Tinnitus—Epirubicin—liver cancer	0.00242	0.00242	CcSEcCtD
Frovatriptan—Haemoglobin—Doxorubicin—liver cancer	0.00242	0.00242	CcSEcCtD
Frovatriptan—Flushing—Epirubicin—liver cancer	0.00241	0.00241	CcSEcCtD
Frovatriptan—Rhinitis—Doxorubicin—liver cancer	0.00241	0.00241	CcSEcCtD
Frovatriptan—Haemorrhage—Doxorubicin—liver cancer	0.0024	0.0024	CcSEcCtD
Frovatriptan—Hypoaesthesia—Doxorubicin—liver cancer	0.00239	0.00239	CcSEcCtD
Frovatriptan—Pharyngitis—Doxorubicin—liver cancer	0.00239	0.00239	CcSEcCtD
Frovatriptan—Urinary tract disorder—Doxorubicin—liver cancer	0.00237	0.00237	CcSEcCtD
Frovatriptan—Urethral disorder—Doxorubicin—liver cancer	0.00236	0.00236	CcSEcCtD
Frovatriptan—Chills—Epirubicin—liver cancer	0.00233	0.00233	CcSEcCtD
Frovatriptan—Arrhythmia—Epirubicin—liver cancer	0.00232	0.00232	CcSEcCtD
Frovatriptan—Visual impairment—Doxorubicin—liver cancer	0.00232	0.00232	CcSEcCtD
Frovatriptan—Mental disorder—Epirubicin—liver cancer	0.00228	0.00228	CcSEcCtD
Frovatriptan—Malnutrition—Epirubicin—liver cancer	0.00226	0.00226	CcSEcCtD
Frovatriptan—Tinnitus—Doxorubicin—liver cancer	0.00224	0.00224	CcSEcCtD
Frovatriptan—Flushing—Doxorubicin—liver cancer	0.00223	0.00223	CcSEcCtD
Frovatriptan—Flatulence—Epirubicin—liver cancer	0.00223	0.00223	CcSEcCtD
Frovatriptan—Tension—Epirubicin—liver cancer	0.00222	0.00222	CcSEcCtD
Frovatriptan—Dysgeusia—Epirubicin—liver cancer	0.00222	0.00222	CcSEcCtD
Frovatriptan—Nervousness—Epirubicin—liver cancer	0.0022	0.0022	CcSEcCtD
Frovatriptan—Back pain—Epirubicin—liver cancer	0.00219	0.00219	CcSEcCtD
Frovatriptan—Muscle spasms—Epirubicin—liver cancer	0.00217	0.00217	CcSEcCtD
Frovatriptan—Chills—Doxorubicin—liver cancer	0.00216	0.00216	CcSEcCtD
Frovatriptan—Arrhythmia—Doxorubicin—liver cancer	0.00215	0.00215	CcSEcCtD
Frovatriptan—Mental disorder—Doxorubicin—liver cancer	0.00211	0.00211	CcSEcCtD
Frovatriptan—Ill-defined disorder—Epirubicin—liver cancer	0.0021	0.0021	CcSEcCtD
Frovatriptan—Malnutrition—Doxorubicin—liver cancer	0.00209	0.00209	CcSEcCtD
Frovatriptan—Agitation—Epirubicin—liver cancer	0.00208	0.00208	CcSEcCtD
Frovatriptan—Flatulence—Doxorubicin—liver cancer	0.00206	0.00206	CcSEcCtD
Frovatriptan—Tension—Doxorubicin—liver cancer	0.00205	0.00205	CcSEcCtD
Frovatriptan—Dysgeusia—Doxorubicin—liver cancer	0.00205	0.00205	CcSEcCtD
Frovatriptan—Malaise—Epirubicin—liver cancer	0.00204	0.00204	CcSEcCtD
Frovatriptan—Nervousness—Doxorubicin—liver cancer	0.00203	0.00203	CcSEcCtD
Frovatriptan—Vertigo—Epirubicin—liver cancer	0.00203	0.00203	CcSEcCtD
Frovatriptan—Syncope—Epirubicin—liver cancer	0.00203	0.00203	CcSEcCtD
Frovatriptan—Back pain—Doxorubicin—liver cancer	0.00202	0.00202	CcSEcCtD
Frovatriptan—Muscle spasms—Doxorubicin—liver cancer	0.00201	0.00201	CcSEcCtD
Frovatriptan—Palpitations—Epirubicin—liver cancer	0.002	0.002	CcSEcCtD
Frovatriptan—Loss of consciousness—Epirubicin—liver cancer	0.00199	0.00199	CcSEcCtD
Frovatriptan—Convulsion—Epirubicin—liver cancer	0.00196	0.00196	CcSEcCtD
Frovatriptan—Ill-defined disorder—Doxorubicin—liver cancer	0.00194	0.00194	CcSEcCtD
Frovatriptan—Myalgia—Epirubicin—liver cancer	0.00193	0.00193	CcSEcCtD
Frovatriptan—Arthralgia—Epirubicin—liver cancer	0.00193	0.00193	CcSEcCtD
Frovatriptan—Chest pain—Epirubicin—liver cancer	0.00193	0.00193	CcSEcCtD
Frovatriptan—Agitation—Doxorubicin—liver cancer	0.00192	0.00192	CcSEcCtD
Frovatriptan—Anxiety—Epirubicin—liver cancer	0.00192	0.00192	CcSEcCtD
Frovatriptan—Discomfort—Epirubicin—liver cancer	0.0019	0.0019	CcSEcCtD
Frovatriptan—Malaise—Doxorubicin—liver cancer	0.00189	0.00189	CcSEcCtD
Frovatriptan—Dry mouth—Epirubicin—liver cancer	0.00188	0.00188	CcSEcCtD
Frovatriptan—Vertigo—Doxorubicin—liver cancer	0.00188	0.00188	CcSEcCtD
Frovatriptan—Syncope—Doxorubicin—liver cancer	0.00188	0.00188	CcSEcCtD
Frovatriptan—Confusional state—Epirubicin—liver cancer	0.00186	0.00186	CcSEcCtD
Frovatriptan—Palpitations—Doxorubicin—liver cancer	0.00185	0.00185	CcSEcCtD
Frovatriptan—Anaphylactic shock—Epirubicin—liver cancer	0.00185	0.00185	CcSEcCtD
Frovatriptan—Loss of consciousness—Doxorubicin—liver cancer	0.00184	0.00184	CcSEcCtD
Frovatriptan—Shock—Epirubicin—liver cancer	0.00182	0.00182	CcSEcCtD
Frovatriptan—Convulsion—Doxorubicin—liver cancer	0.00181	0.00181	CcSEcCtD
Frovatriptan—Tachycardia—Epirubicin—liver cancer	0.0018	0.0018	CcSEcCtD
Frovatriptan—Hyperhidrosis—Epirubicin—liver cancer	0.00178	0.00178	CcSEcCtD
Frovatriptan—Myalgia—Doxorubicin—liver cancer	0.00178	0.00178	CcSEcCtD
Frovatriptan—Chest pain—Doxorubicin—liver cancer	0.00178	0.00178	CcSEcCtD
Frovatriptan—Arthralgia—Doxorubicin—liver cancer	0.00178	0.00178	CcSEcCtD
Frovatriptan—Anxiety—Doxorubicin—liver cancer	0.00178	0.00178	CcSEcCtD
Frovatriptan—Discomfort—Doxorubicin—liver cancer	0.00176	0.00176	CcSEcCtD
Frovatriptan—Anorexia—Epirubicin—liver cancer	0.00176	0.00176	CcSEcCtD
Frovatriptan—Dry mouth—Doxorubicin—liver cancer	0.00174	0.00174	CcSEcCtD
Frovatriptan—Confusional state—Doxorubicin—liver cancer	0.00172	0.00172	CcSEcCtD
Frovatriptan—Anaphylactic shock—Doxorubicin—liver cancer	0.00171	0.00171	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00168	0.00168	CcSEcCtD
Frovatriptan—Shock—Doxorubicin—liver cancer	0.00168	0.00168	CcSEcCtD
Frovatriptan—Insomnia—Epirubicin—liver cancer	0.00167	0.00167	CcSEcCtD
Frovatriptan—Tachycardia—Doxorubicin—liver cancer	0.00167	0.00167	CcSEcCtD
Frovatriptan—Paraesthesia—Epirubicin—liver cancer	0.00166	0.00166	CcSEcCtD
Frovatriptan—Hyperhidrosis—Doxorubicin—liver cancer	0.00165	0.00165	CcSEcCtD
Frovatriptan—Dyspnoea—Epirubicin—liver cancer	0.00165	0.00165	CcSEcCtD
Frovatriptan—Somnolence—Epirubicin—liver cancer	0.00164	0.00164	CcSEcCtD
Frovatriptan—Anorexia—Doxorubicin—liver cancer	0.00163	0.00163	CcSEcCtD
Frovatriptan—Dyspepsia—Epirubicin—liver cancer	0.00163	0.00163	CcSEcCtD
Frovatriptan—Decreased appetite—Epirubicin—liver cancer	0.0016	0.0016	CcSEcCtD
Frovatriptan—Fatigue—Epirubicin—liver cancer	0.00159	0.00159	CcSEcCtD
Frovatriptan—Constipation—Epirubicin—liver cancer	0.00158	0.00158	CcSEcCtD
Frovatriptan—Pain—Epirubicin—liver cancer	0.00158	0.00158	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00156	0.00156	CcSEcCtD
Frovatriptan—Insomnia—Doxorubicin—liver cancer	0.00154	0.00154	CcSEcCtD
Frovatriptan—Paraesthesia—Doxorubicin—liver cancer	0.00153	0.00153	CcSEcCtD
Frovatriptan—Dyspnoea—Doxorubicin—liver cancer	0.00152	0.00152	CcSEcCtD
Frovatriptan—Feeling abnormal—Epirubicin—liver cancer	0.00152	0.00152	CcSEcCtD
Frovatriptan—Somnolence—Doxorubicin—liver cancer	0.00152	0.00152	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Epirubicin—liver cancer	0.00151	0.00151	CcSEcCtD
Frovatriptan—Dyspepsia—Doxorubicin—liver cancer	0.0015	0.0015	CcSEcCtD
Frovatriptan—Decreased appetite—Doxorubicin—liver cancer	0.00148	0.00148	CcSEcCtD
Frovatriptan—Fatigue—Doxorubicin—liver cancer	0.00147	0.00147	CcSEcCtD
Frovatriptan—Pain—Doxorubicin—liver cancer	0.00146	0.00146	CcSEcCtD
Frovatriptan—Constipation—Doxorubicin—liver cancer	0.00146	0.00146	CcSEcCtD
Frovatriptan—Body temperature increased—Epirubicin—liver cancer	0.00146	0.00146	CcSEcCtD
Frovatriptan—Abdominal pain—Epirubicin—liver cancer	0.00146	0.00146	CcSEcCtD
Frovatriptan—Feeling abnormal—Doxorubicin—liver cancer	0.00141	0.00141	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Doxorubicin—liver cancer	0.0014	0.0014	CcSEcCtD
Frovatriptan—Hypersensitivity—Epirubicin—liver cancer	0.00136	0.00136	CcSEcCtD
Frovatriptan—Abdominal pain—Doxorubicin—liver cancer	0.00135	0.00135	CcSEcCtD
Frovatriptan—Body temperature increased—Doxorubicin—liver cancer	0.00135	0.00135	CcSEcCtD
Frovatriptan—Asthenia—Epirubicin—liver cancer	0.00132	0.00132	CcSEcCtD
Frovatriptan—Pruritus—Epirubicin—liver cancer	0.00131	0.00131	CcSEcCtD
Frovatriptan—Diarrhoea—Epirubicin—liver cancer	0.00126	0.00126	CcSEcCtD
Frovatriptan—Hypersensitivity—Doxorubicin—liver cancer	0.00126	0.00126	CcSEcCtD
Frovatriptan—Asthenia—Doxorubicin—liver cancer	0.00123	0.00123	CcSEcCtD
Frovatriptan—Dizziness—Epirubicin—liver cancer	0.00122	0.00122	CcSEcCtD
Frovatriptan—Pruritus—Doxorubicin—liver cancer	0.00121	0.00121	CcSEcCtD
Frovatriptan—Vomiting—Epirubicin—liver cancer	0.00117	0.00117	CcSEcCtD
Frovatriptan—Diarrhoea—Doxorubicin—liver cancer	0.00117	0.00117	CcSEcCtD
Frovatriptan—Headache—Epirubicin—liver cancer	0.00116	0.00116	CcSEcCtD
Frovatriptan—Dizziness—Doxorubicin—liver cancer	0.00113	0.00113	CcSEcCtD
Frovatriptan—Nausea—Epirubicin—liver cancer	0.0011	0.0011	CcSEcCtD
Frovatriptan—Vomiting—Doxorubicin—liver cancer	0.00109	0.00109	CcSEcCtD
Frovatriptan—Headache—Doxorubicin—liver cancer	0.00107	0.00107	CcSEcCtD
Frovatriptan—Nausea—Doxorubicin—liver cancer	0.00101	0.00101	CcSEcCtD
